anticompl
activ
play
import
role
antiinflammatori
effect
tradit
chines
herb
total
flavonoid
sophora
tonkinensi
tfst
inact
complement
system
show
obviou
anticompl
activ
incub
human
intestin
bacteria
vitro
order
discov
metabol
activ
tfst
intestin
flora
constitu
tfst
metabolit
identifi
uplcesiltqm
anticompl
activ
evalu
classic
altern
pathway
result
eighteen
flavonoid
identifi
includ
seven
flavonoid
glycosid
five
aglycon
six
isoprenyl
flavonoid
glycosid
glucosiderhamnosid
sophorabiosid
rutin
isoquercitrin
quercitrin
ononin
trifolirhizin
metabol
correspond
aglycon
differ
extent
human
intestin
bacteria
result
content
five
aglycon
highli
increas
h
howev
chang
occur
six
isoprenyl
flavonoid
interestingli
three
aglycon
quercetin
formononetin
maackiain
significantli
potent
anticompl
activ
prototyp
glycosid
result
indic
enhanc
tfst
anticompl
activ
attribut
activ
aglycon
especi
formononetin
quercetin
produc
human
intestin
bacteria
aglycon
like
among
potenti
activ
compon
tonkinensi
inhibit
inflamm
effect
root
rhizom
sophora
tonkinensi
known
shandougen
tradit
chines
medicin
record
chines
pharmacopoeia
wide
use
treatment
laryngopharyng
inflamm
throat
pain
oral
administr
flavonoid
alkaloid
two
kind
major
compon
tonkinensi
pharmacolog
studi
report
flavonoid
tonkinensi
possess
signific
bioactiv
antioxid
anticanc
antigastr
ulcer
inhibit
gastric
acid
secret
effect
alkaloid
tonkinensi
exhibit
antivir
activ
hepat
b
viru
hbv
influenza
viru
h
n
coxsacki
viru
b
cvb
tradit
chines
medicin
given
oral
chemic
compound
inevit
contact
intestin
flora
within
gastrointestin
tract
moreov
compon
metabol
intestin
bacteria
absorb
digest
tract
research
herbal
compon
metabol
intestin
flora
greatli
signific
understand
potenti
biolog
characterist
system
complement
play
domin
role
regul
host
defens
howev
pathogenesi
diseas
sever
acut
respiratori
syndrom
sar
acut
respiratori
distress
syndrom
ard
may
caus
complement
system
excess
activ
lead
system
inflamm
respons
notabl
tradit
chines
medicin
commonli
benefici
effect
infecti
diseas
inhibit
inflamm
reduc
fever
mechan
probabl
relat
inhibit
excess
activ
complement
system
vivo
henc
discoveri
applic
complement
inhibitor
becom
potenti
therapeut
strategi
treatment
infecti
diseas
interestingli
previou
studi
found
total
flavonoid
tonkinensi
tfst
absenc
complement
inhibitori
activ
show
obviou
anticompl
activ
incub
human
intestin
bacteria
howev
intestin
bacteria
http
elsevi
bv
right
reserv
distinct
influenc
weak
anticompl
activ
total
alkaloid
tonkinensi
specul
tfst
might
key
effect
compon
exhibit
anticompl
activ
vivo
metabol
intestin
bacteria
find
structur
activ
tfst
chang
human
intestin
bacteria
tfst
extract
incub
human
fecal
microflora
studi
compon
tfst
metabolit
recogn
compar
via
uplcesiltqm
well
anticompl
activ
vitro
dri
root
tonkinensi
purchas
leiyunshang
drug
store
shanghai
authent
prof
daofeng
chen
fudan
univers
voucher
specimen
deposit
school
pharmaci
fudan
univers
shanghai
peopl
republ
china
sheep
blood
cell
prepar
alsev
solut
antisheep
erythrocyt
antibodi
provid
prof
yunyi
zhang
guinea
pig
serum
prepar
healthi
guinea
pig
rabbit
blood
cell
prepar
ear
vein
new
zealand
white
rabbit
purchas
laboratori
anim
research
institut
fudan
univers
shanghai
china
normal
human
serum
nh
prepar
healthi
male
donor
age
year
old
buffer
vb
isoton
veron
buffer
salin
contain
mmoll
ca
mmoll
mg
egtavb
veron
buffer
salin
contain
mmoll
mg
mmoll
ethylen
glycol
tetraacet
acid
refer
substanc
puriti
ononin
formononetin
trifolirhizin
maackiain
rutin
quercitrin
isoquercitrin
quercetin
daidzein
genistein
sophorabiosid
purchas
meilun
biolog
technolog
co
ltd
shanghai
china
uplc
grade
acetonitril
methanol
purchas
merck
darmstadt
germani
ultrapur
water
purifi
milliq
water
purif
system
millipor
boston
usa
gener
anaerob
medium
broth
gam
broth
purchas
meilun
biolog
technolog
co
ltd
shanghai
china
reagent
chemic
compound
analyt
grade
analys
tfst
metabolit
perform
use
uplc
system
dionex
ultim
condit
autosampl
c
qualit
analysi
separ
perform
c
column
mm
id
thermo
finnigan
san
jose
ca
usa
temperatur
column
set
c
use
uplc
system
thermo
finnigan
san
jose
ca
usa
mobil
phase
consist
formic
acid
add
ultrapur
water
vv
acetonitril
b
use
gradient
elut
b
min
b
min
flow
rate
mlmin
uv
absorpt
set
nm
inject
volum
l
mass
spectra
set
rang
mz
electrospray
ioniz
esi
sourc
acquir
neg
ion
mode
ion
spray
voltag
kv
temperatur
capillari
maintain
c
nitrogen
use
sheath
ga
auxiliari
ga
flow
rate
arbitrari
unit
arbitrari
unit
respect
helium
use
damp
ga
collis
ga
dri
root
tonkinensi
g
extract
three
time
use
ethanol
h
heat
reflux
method
filtrat
filtrat
collect
evapor
vacuum
ethanol
extract
mix
water
purifi
macropor
resin
column
elut
success
distil
water
time
column
volum
use
ethanol
wash
time
column
volum
ethanol
elut
collect
evapor
vacuum
yield
tfst
g
fresh
fecal
sampl
obtain
healthi
human
volunt
four
male
four
femal
year
age
neither
gastrointestin
diseas
histori
use
antibiot
least
six
month
experi
homogen
time
volum
gener
anaerob
medium
broth
immedi
remov
residu
use
gauz
filter
intestin
bacteri
suspens
cultur
anaerob
system
nitrogen
carbon
dioxid
hydrogen
c
mg
tfst
ad
ml
human
intestin
bacteri
suspens
mixtur
anaerob
incub
c
h
incub
solut
respect
taken
extract
water
satur
nbutanol
three
time
extract
centrifug
rpm
min
c
supernat
evapor
vacuum
dryness
residu
dissolv
ml
meoh
centrifug
rpm
min
c
supernat
analyz
uplcesiltqm
chemic
constitu
chang
tfst
also
analyz
incub
time
point
h
use
method
mg
refer
substanc
sophorabiosid
ononin
trifolirhizin
rutin
quercitrin
isoquercitrin
ad
ml
human
intestin
bacteri
suspens
incub
anaerob
h
c
extract
nbutanol
purifi
centrifug
final
methanol
solut
also
analyz
use
uplcesiltqm
anticompl
activ
classic
pathway
sophorabiosid
rutin
isoquercitrin
quercitrin
ononin
trifolirhizin
daidzein
genistein
quercetin
formononetin
maackiain
heparin
sodium
posit
control
evalu
accord
mayer
modifi
method
anticompl
activ
altern
pathway
measur
accord
klerx
method
evalu
effect
sophorabiosid
rutin
isoquercitrin
quercitrin
ononin
trifolirhizin
daidzein
genistein
quercetin
formononetin
maackiain
secret
lipopolysaccharid
lp
use
initi
cell
murin
macrophag
cell
line
maintain
dmem
gibco
ny
usa
contain
vv
fetal
bovin
serum
gibco
cultur
plate
cell
per
well
c
humidifi
atmospher
co
lp
ngml
test
sampl
ad
correspond
well
incub
h
content
cultur
media
measur
accord
colorimetr
method
use
griess
reagent
metabolit
fig
observ
compar
tfst
fig
peak
height
peak
area
chang
significantli
chromatograph
peak
tfst
identifi
compar
retent
time
molecular
ion
peak
uv
spectra
refer
substanc
uplcesiltqm
neg
ioniz
mode
data
summar
tabl
fragment
pathway
similar
compound
except
da
oh
less
everi
fragment
ion
compound
besid
consid
molecular
weight
compound
da
glcrha
specul
compound
metabol
pathway
thu
compound
identifi
glucosiderhamnosid
compound
show
typic
fragment
pattern
isoprenyl
flavonoid
could
distinguish
characterist
aion
b
ion
accord
retro
diel
alder
rda
cleavag
fig
characterist
fragment
origin
degrad
differ
isopenten
group
msm
spectra
fig
result
summar
tabl
tabl
retent
time
rt
molecular
ion
peak
peak
area
ratio
flavonoid
glycosid
aglycon
tfst
metabolit
compound
total
eighteen
compound
tfst
metabolit
identifi
fig
includ
seven
flavonoid
glycosid
glucosiderhamnosid
sophorabiosid
rutin
isoquercitrin
quercitrin
ononin
trifolirhizin
five
flavonoid
aglycon
daidzein
genistein
quercetin
formononetin
maackiain
six
isoprenyl
flavonoid
kurarinon
sophoradin
sophoradochromen
sophoranon
sophoranochromen
area
ratio
peak
tfst
metabolit
tabl
indic
flavonoid
glycosid
decreas
flavonoid
aglycon
increas
human
intestin
bacteria
isoprenyl
flavonoid
chang
fig
tabl
content
chang
seven
flavonoid
glycosid
five
flavonoid
aglycon
tfst
metabolit
determin
semi
quantit
peak
area
incub
time
point
h
h
tabl
regress
equat
correl
coeffici
precis
lod
refer
standard
also
evalu
tabl
content
glucosiderhamnosid
sophorabiosid
rutin
isoquercitrin
quercitrin
ononin
trifolirhizin
declin
time
went
exactli
opposit
content
chang
daidzein
genistein
quercetin
formononetin
maackiain
fig
base
content
chang
well
chemic
structur
twelv
constitu
tfst
infer
seven
flavon
glycosid
convert
aglycon
accordingli
human
intestin
bacteria
uplc
chromatogram
refer
standard
show
metabol
result
fig
confirm
transform
glycosid
respect
aglycon
intestin
bacteria
base
result
metabol
pathway
flavonoid
human
intestin
bacteria
shown
fig
noteworthi
rutin
isoquercitrin
quercitrin
metabol
quercetin
sinc
commerci
avail
refer
standard
glucosiderhamnosid
hard
verifi
metabolit
directli
convers
refer
product
human
intestin
flora
accord
chemic
structur
fragment
pattern
metabol
result
sophorabiosid
specul
glucosiderhamnosid
metabol
daidzein
human
intestin
bacteria
result
suggest
oglycosid
flavonoid
tfst
easili
convert
correspond
aglycon
intestin
flora
transform
tonkinensi
flavonoid
seven
compon
chang
among
compon
rutin
isoquercitrin
quercitrin
ononin
trifolirhizin
metabol
quercetin
formononetin
maackiain
anticompl
activ
remark
improv
particularli
formononetin
ch
mgml
ap
mgml
metabolit
ononin
ch
mgml
ap
ne
show
signific
activ
compar
posit
inhibitor
howev
neither
glycosid
aglycon
isoflavon
sophorabiosid
daidzein
date
present
mean
sd
n
p
p
p
p
compar
initi
peak
area
compound
anticompl
activ
flavonoid
metabolit
mean
sd
n
p
p
p
compar
correspond
flavonoid
glycosid
genistein
show
anticompl
activ
tabl
although
rutin
isoquercitrin
quercitrin
demonstr
anticompl
activ
classic
pathway
altern
pathway
common
metabolit
quercetin
ch
mgml
ap
mgml
quit
potent
besid
isoprenyl
flavonoid
inact
vitro
antiinflammatori
assay
fig
show
compar
cell
lp
group
rutin
quercitrin
quercetin
formononetin
treat
cell
exhibit
signific
decreas
product
p
hand
result
consist
anticompl
activ
quercetin
formononetin
show
better
activ
glycosid
rutin
isoquercitrin
ononin
meanwhil
statist
differ
quercitrin
quercetin
howev
maackiain
trifolirhizin
weak
anticompl
activ
antiinflammatori
activ
result
reveal
metabol
activ
tfst
human
intestin
flora
attribut
content
increas
potent
flavonol
quercetin
isoflavon
formononetin
aglycon
kind
transform
also
occur
intestin
bacteria
metabol
inact
flavon
glycosid
scutellaria
baicalensi
root
anticompl
aglycon
vitro
vivo
aglycon
like
quercetin
formononetin
might
potenti
effect
substanc
tonkinensi
perform
inhibit
inflamm
action
vivo
previou
studi
show
bacteroidet
proteobacteria
firmicut
account
human
intestin
bacteria
ononin
quercitrin
metabol
specif
human
intestin
bacteria
three
group
includ
bacteroid
escherichia
coli
lactobacillu
enterococcu
faecali
result
show
ononin
could
transform
four
bacteria
formononetin
fig
howev
bacteroid
could
convert
quercitrin
quercetin
fig
reason
might
differ
glycosid
bond
two
compound
ononin
common
natur
quercitrin
thu
could
metabol
easili
intestin
bacteria
hand
four
bacteria
quit
differnt
efficineci
metabol
ononin
enterococcu
faecali
transform
almost
compound
aglycon
besid
root
sophora
flavescen
ait
anoth
commonli
use
medicin
plant
sophora
found
contain
similar
chemic
constitu
tonkinensi
includ
isoprenyl
flavonoid
quinolizidin
alkaloid
howev
clinic
applic
complet
differ
tonkinensi
frequent
use
intern
treat
acut
throat
infect
flavescen
mostli
use
extern
treatment
skin
diseas
eczema
dermat
differ
flavonoid
constitu
could
serv
qualit
marker
identif
tonkinensi
flavescen
flavescen
root
bare
contain
flavonoid
glycosid
mainli
contain
isoprenyl
flavonoid
fig
inact
complement
system
unabl
metabol
intestin
bacteria
expect
almost
chang
detect
flavonoid
flavescen
incub
human
intestin
bacteria
except
trifolirhizin
metabol
maackiain
fig
tabl
result
explain
differ
effect
administr
rout
flavescen
tonkinensi
current
studi
show
presenc
intestin
flora
play
key
role
metabol
activ
tfst
oral
administr
content
flavonoid
aglycon
potent
anticompl
activ
enhanc
significantli
hydrolyt
action
intestin
flora
flavonoid
glycosid
among
eighteen
flavonoid
identifi
use
uplcesiltqm
method
isoflavon
flavonol
aglycon
formononetin
quercetin
three
flavonol
glycosid
rutin
isoquercitrin
quercitrin
major
anticompl
constitu
tfst
taken
qualiti
marker
tonkinensi
root
vivo
antiinflammatori
anticompl
effect
formononetin
potent
constit
metabolit
tfst
investig
near
futur
author
declar
known
compet
financi
interest
person
relationship
could
appear
influenc
work
report
paper
